616-P: CGM Use and A1C: A Transatlantic Comparison of the DPV Initiative and T1D Exchange Quality Improvement Collaborative (T1DX-QI)

616-P: CGM Use and A1C: A Transatlantic Comparison of the DPV Initiative and T1D Exchange Quality Improvement Collaborative (T1DX-QI)

The utility of CGM to improve glycemic control and QoL is well established; however, real-world use of CGM varies among people with T1D. The objectives of this study were to analyze the rates of CGM use and association to glycemic control (A1c) in the U.S. T1DX-QI Collaborative and the German-Austri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser: DESALVO, DANIEL, LANZINGER, STEFANIE, NOOR, NUDRAT, STEIGLEDER-SCHWEIGER, CLAUDIA, EBEKOZIEN, OSAGIE, SENGBUSCH, SIMONE VON, JONES, NANA-HAWA, LAUBNER, KATHARINA, MAAHS, DAVID M., HOLL, REINHARD W.
Format: Artikel
Sprache:eng
Schlagworte:
Age composition
Age groups
Collaboration
Diabetes
Glucose
Glucose monitoring
Initiatives
Patients
Pediatrics
Quality control
Quality improvement
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The utility of CGM to improve glycemic control and QoL is well established; however, real-world use of CGM varies among people with T1D. The objectives of this study were to analyze the rates of CGM use and association to glycemic control (A1c) in the U.S. T1DX-QI Collaborative and the German-Austrian DPV Initiative. EMR data were analyzed for 15,113 T1DX-QI patients and 41,640 DPV patients with clinic visits in 2019. Mean age for T1DX-QI patients was 19.6 13.2 yrs, 48.7% were female, and A1c was 8.6 2.0%. Among DPV patients, mean age was 21.9 18.0 yrs, 46.9% were female, and A1c was 7.7 1.4%. Overall CGM use in T1DX-QI was 53.3% with highest rates in adults (age distribution
ISSN:0012-1797
1939-327X
DOI:10.2337/db21-616-P